AMRIX (Cyclobenzaprine Hydrochloride
Extended-Release Capsules) is approved for use along with rest and physical therapy to help control muscle spasm associated with acute, painful musculoskeletal conditions, added Watson Pharmaceuticals Inc.
Petith, 24, of 93 Patriots Road, East Templeton, was arraigned on charges of possession of OxyContin with the intent to distribute, possession of OxyContin, possession of cyclobenzaprine hydrochloride
with the intent to distribute and possession of cyclobenzaprine hydrochloride
The company's proprietary products in the United States include: AMRIX (cyclobenzaprine hydrochloride
extended-release capsules), TREANDA (bendamustine hydrochloride) for Injection, FENTORA (fentanyl buccal tablet) (C-II), PROVIGIL (modafinil) Tablets (C-IV), TRISENOX (arsenic trioxide) injection, GABITRIL (tiagabine hydrochloride), NUVIGIL (armodafinil) Tablets (C-IV) and ACTIQ (oral transmucosal fentanyl citrate) (C-II).
The company's proprietary products in the United States include: PROVIGIL(r) (modafinil) Tablets [C-IV], FENTORA(r) (fentanyl buccal tablet) [C-II], TRISENOX injection, TREANDA, AMRIX(r) (cyclobenzaprine hydrochloride
extended-release capsules), VIVITROL(r) (naltrexone for extended-release injectable suspension), GABITRIL(r) (tiagabine hydrochloride), NUVIGIL(tm) (armodafinil) Tablets [C-IV] and ACTIQ(r) (oral transmucosal fentanyl citrate) [C-II].
This patent, "Eutectic Formulations of Cyclobenzaprine Hydrochloride
and Amitriptyline Hydrochloride," is directed to a unique eutectic that characterizes TNX-102 SL*, and claims pharmaceutical compositions containing that eutectic and methods of making those compositions.
16 May 2011 - US generic and specialty pharmaceutical firm Mylan Inc (NASDAQ: MYL) said on Friday that its subsidiary Mylan Pharmaceuticals Inc has launched Cyclobenzaprine Hydrochloride
(HCl) Extended-release (ER) Capsules, 15 mg and 30 mg.
Specialist pharmaceutical company Mylan Inc (Nasdaq:MYL) reported on Friday the launch of its Cyclobenzaprine Hydrochloride
(HCl) Extended-release (ER) Capsules, 15 mg and 30 mg in the market.